Safety and Efficacy of T Cell Genetic Immunotherapy for HIV
Clinical trial NCT00131560 · UNKNOWN
Trial details
- NCT number
- NCT00131560
- Sponsor
- VIRxSYS Corporation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2008-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.